Table 1.
Typical mitochondrial myopathies that are generally multisystem disorders.
Myophathy | Pathogenesis | Inheritance | Age | Mitochondrial Target | Main Symptoms | Prognosis |
---|---|---|---|---|---|---|
Kearns-Sayre syndrome (KSS) | single large-scale deletions of mtDNA | generally, not inherited. (sporadic), rare case of mitochondrial, autosomal dominant, or autosomal recessive | before the age of 20 | Mainly cyt C oxidase | progressive external ophthalmoplegia, and pigmentary retinopathy. cardiac conduction block, cerebrospinal fluid protein greater than 100 mg/dL, cerebellar ataxia, short stature, deafness, dementia, and endocrine abnormalities | slowly progressive disorder. Prognosis related to level of organs involvment. arrythmias |
Chronic progressive external ophthalmoplegia (CPEO) | Deletion/mutation of mtDNA (i.e., tRNA at nucleotide 3243 in which there is an A to G), or nuclear genes: POLG, C10orf2, RRM2B, SLC25A4, POLG2, DGUOK, SPG7 | sporadic, mitochondrial, autosomal dominant, or autosomal recessive | Aroud 40s years | defective function of oxidative phosphorylation | Ptosis, Limited eye movements, and Hearing loss, Mild muscle weakness, dysphagia, cataracts | prognosis depends on the associated features, |
Leigh syndrome | Different pathogenic mutations identified in over 85 genes | nuclear or mtDNA mutations. | Generally, infancy and childhhod | Dysfunction of pyruvate dehydrogenase complex and oxidative phosphorylation | Mainly developmental delay or psychomotor regression failure to thrive, weakness/hypertonia, ataxia, oculomotor palsy, seizures, lactic acidosis | generally poor |
Mitochondrial DNA depletion syndrome (MDS) | Different mutations in the TK2,SUCLA2, SUCLG1, RRM2B, DGUOK, MPV17, POLG, C10orf2; TYMP genes | Maternal and autosomal recessive | newborns, infants, children, or adult | different subunits of mitochondrial respiratory chain complexes | Different clinical pictures: Myopathic; encephalomyopathic; hepatocerebral; neurogastrointestinal | generally poor |
Mitochondrial encephalomyopathy, lactic acidosis and stroke like episodes (MELAS) | mtDNA: m.3243A > G, gene MT-TL (80% of cases) and m.3271T > C tRNA mutation (10%) | maternally inherited | childhood | tRNA and NADH dehydrogenase | stroke-like episode, hemiparesis, hemianopia, or cortical blindness. focal or generalized seizures, recurrent migraine, vomiting, short stature, hearing loss, and muscle weakness. | poor |
Myoclonus epilepsy with ragged red fibers (MERRF) | A-to-G transition at nucleotide 8344 (m.8344A > G) of the MT-TK genetRNA (Lys) | Spontaneous mutations, maternally inherited | Childhood, adolescence or early adulthood | oxidative phosphorylation | myoclonus, epilepsy, ataxia, myopathy, dementia, optic atrophy, deafness, peripheral neuropathy, spasticity, cardiomyopathy with WPW syndrome. | Generally poor. It can depend on age, severity of symptoms, organs involved. |
Maternally inherited deafness and diabetes (MIDD) | mutation in mtDNA gene MT-TL1, encoding tRNA for leucine, and in rare cases in MT-TE and MT-TK genes, encoding tRNAs for glutamic acid, and lysine, respectively. | maternally inherited | mean age of onset is 30–40 years | defective function of oxidative phosphorylation | Diabetes, deafness, Chorioretinal abnormality, Dyschezia, Macular dystrophy, Malabsorption, Cerebellar hypoplasia, arrhythmias, heart failure, ophthalmoplegia, Muscular weakness, | prognosis for MIDD is better than that for MELAS |
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) | Mutations of TYMP gene (nDNA) | autosomal recessive | range from 5–60 years of age | defective function of oxidative phosphorylation | gastrointestinal disorders (dysphagia, cramping, vomiting, diarrhea, gastroparesis intestinal pseudo-obstruction) related to abnormal bowel motility. Neurological symptoms includes chronic progressive ophthalmoplegia, sensorimotor peripheral neuropathy | progressive degenerative disorder with a poor prognosis |
Neuropathy, ataxia, and retinitis pigmentosa (NARP) | More frequent: m.8993T > C/G subunit 6 of mt ATPase gene | maternally inherited | Childhood | defective function of oxidative phosphorylation | sensory neuropathy, muscle weakness; ataxia, retinitis pigmentosa, developmental delay, seizures, dementia, deafness, arrhythmias. | poor prognosis |